Suppr超能文献

使用皮内注射六氟化硫微泡的超声造影在乳腺癌手术中识别前哨淋巴结:一项临床试验

Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride for Identification of Sentinel Lymph Nodes During Breast Cancer Surgery: A Clinical Trial.

作者信息

Buonomo Oreste Claudio, Materazzo Marco, Pellicciaro Marco, Iafrate Giada, Ielpo Benedetto, Rizza Stefano, Pistolese Chiara Adriana, Perretta Tommaso, Meucci Rosaria, Longo Benedetto, Cervelli Valerio, Vanni Gianluca

机构信息

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy;

出版信息

Anticancer Res. 2023 Feb;43(2):557-567. doi: 10.21873/anticanres.16192.

Abstract

BACKGROUND/AIM: Sentinel lymph node (SLN) procedures have gained popularity in early breast cancer thanks to the reduction of surgical side-effects. The standard SLN mapping procedure uses Tc-nanocolloid human serum albumin with/without blue dye; limitations include logistical challenges and adverse reactions. Recently, contrast-enhanced ultrasound (CEUS) using sulfur hexafluoride has emerged as a promising technique for SLN mapping. Our study aimed to compare the CEUS technique with the standard isotope method.

MATERIALS AND METHODS

AX-CES, a prospective, monocentric, single-arm phase-3 study was designed (EudraCT: 2020-000393-20). Inclusion criteria were histologically diagnosed early breast cancer eligible for upfront surgery and SLN resection, bodyweight 40-85 kg, and no prior history of ipsilateral surgery or radiotherapy. All patients underwent CEUS prior to surgery and blue dye injection was performed in areas with contrast accumulation. After the experimental procedure, all patients underwent the standard mapping procedure and SLN frozen section assessment was performed. Data on the success rate, systemic reactions, mean procedure time, CEUS appearance, SLN number, and concordance with standard mapping procedure were collected.

RESULTS

Among 16 cases, a median of two SLNs were identified during CEUS. In all cases, at least one SLN was identified by CEUS (100%). In six cases, SLNs were classified during CEUS as abnormal, which was confirmed by definitive staining in four cases. After the standard mapping technique, in 15 out of the 16 cases (87.50%), at least one SLN from the standard mapping procedure was marked with blue dye in the CEUS procedure. In our series, sensitivity and specificity of SLN detection by CEUS were 75% and 100%, respectively.

CONCLUSION

CEUS is a safe and manageable intraoperative procedure. When compared with standard techniques, US appearance during CEUS may provide additional information when associated with histological assessment.

摘要

背景/目的:前哨淋巴结(SLN)手术因减少手术副作用而在早期乳腺癌中受到欢迎。标准的SLN定位手术使用锝标记的纳米胶体人血清白蛋白加/不加蓝色染料;其局限性包括后勤挑战和不良反应。最近,使用六氟化硫的对比增强超声(CEUS)已成为一种有前景的SLN定位技术。我们的研究旨在比较CEUS技术与标准同位素方法。

材料与方法

设计了AX-CES,一项前瞻性、单中心、单臂3期研究(欧盟临床试验注册号:2020-000393-20)。纳入标准为组织学诊断为适合 upfront 手术和 SLN 切除的早期乳腺癌、体重40-85 kg、同侧无既往手术或放疗史。所有患者在手术前接受CEUS检查,并在造影剂积聚区域注射蓝色染料。实验步骤完成后,所有患者接受标准定位手术并进行SLN冰冻切片评估。收集成功率、全身反应、平均手术时间、CEUS表现、SLN数量以及与标准定位手术的一致性等数据。

结果

16例患者中,CEUS检查期间发现的SLN中位数为2个。所有病例中,CEUS至少识别出1个SLN(100%)。6例病例中,CEUS将SLN分类为异常,其中4例经最终染色证实。标准定位技术后,16例中有15例(87.50%)在CEUS手术中至少有1个标准定位手术的SLN被蓝色染料标记。在我们的系列研究中,CEUS检测SLN的敏感性和特异性分别为75%和100%。

结论

CEUS是一种安全且可控的术中操作。与标准技术相比,CEUS期间的超声表现与组织学评估相结合时可能提供额外信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验